Dev Labtech Venture Limited Completes 32nd AGM with All Seven Resolutions Passed

Dev Labtech Venture Limited held its 32nd Annual General Meeting on September 27, 2025, via video conferencing from 1:00 PM to 1:11 PM. All seven resolutions were passed with 100% approval from voting shareholders. The approved resolutions included adoption of financial statements, appointment of Mrs. Dimple Jay Donda as director, appointment of M/s. H A R & Co. as statutory auditors, approval for material related party transactions, shifting registered office from Bhavnagar to Surat within Gujarat, and remuneration approvals for Chairman and Managing Director Mr. Jerambhai Lavjibhai Donda and Whole-time Director Mr. Jay Jerambhai Donda. The meeting had 969 shareholders on record date September 20, 2025, with 16 shareholders attending through video conferencing (5 promoters and 11 public shareholders). Mr. Ricky Kapadia of RPK & Associates served as scrutinizer for the e-voting process.

Dev Labtech Venture Receives BSE Trading Approval for 5.6 Lakh Equity Shares

Dev Labtech Venture Limited has received trading approval from BSE for 5,60,000 equity shares of Rs. 10 each issued at a premium of Rs. 52. The shares were issued to promoters on a preferential basis through warrant conversion, bearing distinctive numbers from 11303140 to 11863139. BSE granted the trading approval on August 01, 2025, and the securities will be listed and tradable on the exchange from August 04, 2025. The company trades under scrip code 543848 with scrip ID DEVLAB on BSE SME.

Dev Labtech Acquires Shares in U.S. Subsidiary

Dev Labtech has purchased shares in its U.S. subsidiary to expand its international operations. The company aims to grow its presence in the global market through this strategic move.